Truncation of the Human Immunodeficiency Virus-Type-2 Envelope Glycoprotein Allows Efficient Pseudotyping of Murine Leukemia Virus Retroviral Vector Particles
Authors:
- Martin HöhneMHMartin Höhne
- Sonja ThalerbSTSonja Thalerb
- Jan C. DuddaJDJan C. Dudda
- Bernd GronerabBGBernd Gronerab
- Barbara S. SchnierleBSBarbara S. Schnierle
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Inhibition of Cellular Glycoprotein Incorporation into Human Immunodeficiency Virus-like Particles by Coexpression of Additional Cellular Interaction PartnerVirology, 1998
- Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cellsGene Therapy, 1998
- Expression cloning of new receptors used by simian and human immunodeficiency virusesNature, 1997
- Functional antagonism between the retinoic acid receptor and the viral transactivator BZLF1 is mediated by protein-protein interactions.Proceedings of the National Academy of Sciences, 1995
- Production of high-titer helper-free retroviruses by transient transfection.Proceedings of the National Academy of Sciences, 1993
- Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.Proceedings of the National Academy of Sciences, 1993
- SIV adaption to human cellsNature, 1989
- Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone.Proceedings of the National Academy of Sciences, 1989
- West African HIV-2-Related Human Retrovirus with Attenuated CytopathicityScience, 1988
- Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retrovirusesNature, 1987